Certara News and Activities

Presence

Certara provides software and consulting for drug research and development. Its products support data analysis, biosimulation, and regulatory planning for pharmaceutical, biotechnology, and medical research customers.

Certara products and services overview:

Drug development software
Biosimulation tools
Regulatory services
Data analytics
Clinical trial solutions
Research consulting

Revenue: ~$400 million

Employees: 1,450

Headquarters: Princeton, United States (USA)

Certara is one of the...

Certara is a company listed under the stock ticker CERT (US).

Acquisition, funding and merger involving Certara.

Veristat has announced the acquisition of Certara (posted on April 22 2026).

Executives

View the org chart displaying its 30 main executives

Most searched biographies at Certara

Popular executive movements at Certara

John Gallagher, Chief Financial Officer, will leave the company on Jul. 14, 2026 (posted on June 18 2026).
Faiz Mohammed will join the company as Interim Chief Financial Officer on Jul. 14, 2026 (posted on June 18 2026).
David Meats, Director, Regulatory Science and Medical Affairs, has left the company (posted on June 15 2026).

Click here to view some more movements at Certara

Create your alert
to follow the executive moves at Certara.